Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the omicron BA.2.86/JN.1 period among older adults in seven European countries: a VEBIS-EHR network study.
Nunes B, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Moustsen-Helms IR, Sacco C, Fabiani M, Castilla J, Martínez-Baz I, Meijerink H, Machado A, Soares P, Ljung R, Pihlström N, Nardone A, Bacci S, Monge S; VEBIS-EHR working group; VEBIS EHR working group names:. Nunes B, et al. Among authors: van evercooren i. Expert Rev Vaccines. 2024 Nov 13. doi: 10.1080/14760584.2024.2428800. Online ahead of print. Expert Rev Vaccines. 2024. PMID: 39535047 Free article.
Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium.
Hubin P, Van den Borre L, Braeye T, Cavillot L, Billuart M, Stouten V, Nasiadka L, Vermeiren E, Van Evercooren I, Devleesschauwer B, Catteau L, van Loenhout JAF. Hubin P, et al. Among authors: van evercooren i. Vaccine X. 2024 May 3;18:100496. doi: 10.1016/j.jvacx.2024.100496. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38779406 Free PMC article.
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Monge S, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Sacco C, Mateo-Urdiales A, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Kristoffersen AB, Machado A, Soares P, Nardone A, Bacci S, Kissling E, Nunes B; VEBIS‐EHR Working Group. Monge S, et al. Among authors: van evercooren i. Influenza Other Respir Viruses. 2024 Apr;18(4):e13292. doi: 10.1111/irv.13292. Influenza Other Respir Viruses. 2024. PMID: 38654485 Free PMC article.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Fontán-Vela M, Kissling E, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Fabiani M, Mateo-Urdiales A, AlKerwi A, Schmitz S, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Starrfelt J, Nunes B, Caetano C, Derrough T, Nardone A, Monge S; VEBIS-Lot4 working group; VEBIS-Lot 4 working group. Fontán-Vela M, et al. Among authors: van evercooren i. Euro Surveill. 2024 Jan;29(1):2300670. doi: 10.2807/1560-7917.ES.2024.29.1.2300670. Euro Surveill. 2024. PMID: 38179626 Free PMC article.
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Kislaya I, Sentís A, Starrfelt J, Nunes B, Martínez-Baz I, Nielsen KF, AlKerwi A, Braeye T, Fontán-Vela M, Bacci S, Meijerink H, Castilla J, Emborg HD, Hansen CH, Schmitz S, Van Evercooren I, Valenciano M, Nardone A, Nicolay N, Monge S; VEBIS‐Lot4 working group. Kislaya I, et al. Among authors: van evercooren i. Influenza Other Respir Viruses. 2023 Nov;17(11):e13195. doi: 10.1111/irv.13195. Influenza Other Respir Viruses. 2023. PMID: 38019704 Free PMC article.
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium.
Vermeiren E, van Loenhout JAF, Nasiadka L, Stouten V, Billuart M, Van Evercooren I, Catteau L, Hubin P. Vermeiren E, et al. Among authors: van evercooren i. BMC Res Notes. 2023 Nov 11;16(1):328. doi: 10.1186/s13104-023-06608-4. BMC Res Notes. 2023. PMID: 37951923 Free PMC article.